News articles

Restrictions on extensions to the duration of grant agreements, and respect of reporting deadlines

Restrictions on extensions to the duration of grant agreements, and respect of reporting deadlines

Recent experience has shown that nearly 50% of grants are not completed in the timescale set out in the Grant Agreement, but are extended through an amendment. This level of amendments shows that it is no longer the exceptional procedure that it was intended to be, but has become a common practice in the 7th

iHIVARNA 2nd General Assembly Meeting

The second General Assembly Meeting of the iHIVARNA Project has been held last 16-17 of June in Rotterdam. During the meeting the members of the Consortium presented the work carried out during the first 6 months of the project and discussed the work plan for the next 6 months. Next face-to-face meeting will take place

Capturing Participant Information for Mucosal Sampling: An Investigators Guide

A new resource for organizations and investigators engaging in clinical studies with a mucosal immunology component. The Global HIV Vaccine Enterprise, in collaboration with the National Institute of Allergy and Infectious Diseases and the HIV Mucosal Immunology Group has developed an Investigator’s Guide to Capture Participant Information for Mucosal Sampling Mucosal immune responses and mucosal

2014 DNA Vaccine conference

The International Society of DNA Vaccines is an organization created to facilitate the advancement of therapeutic and preventive DNA vaccines. The society is comprised of international scientists and researchers who have dedicated their careers to improving world health and the advancement of DNA vaccines and therapies. The International Society of DNA Vaccines has released some

iHIVARNA cited in the Netherlands media

The iHIVARNA project has been cited in De Telegraaf, the top 1 newspaper of the Netherlands. It also was quoted on RTV Rijnmond, one of the biggest regional radio and TV press organization in the Rotterdam-The Hague region (province of Zuid-Holland). The media highlighted the main objectives of the project, and the importance of the

HORIZON 2020 – The EU Framework Programme for Research and Innovation

Horizon 2020 is the biggest EU research and innovation programme ever with nearly €80 billion of funding available over 7 years: 2014 to 2020. Europe must invest more and better in research and innovation. More research and innovation are critical in order to create sustainable economic growth and jobs and to reinforce Europe’s international competitiveness.

New Horizons for Vaccine Research & Innovation Conference

European Commission has organized a Conference to bring together researcher, community and industry interested in this field with the final aim of support this important health topic. Curevac won the Vaccine Prize for Innovation with RNA vaccines.   The conference had 3 parts: Community: it was explained the importance of how communicate better the advantages

iHIVARNA Kick-off Meeting in the media

The European project is cited in several Spanish newspapers, TV and radio stations On the week of the 9th December 2014 the iHIVARNA project Kick-off meeting held in Barcelona received important media coverage in Spain. The project was cited in 10 national and local TV stations and in 18 radio stations; and was presented in